Vimarsana
Biggest News Aggregation in the World

Page 5 - Patrick Wingrove News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrick Wingrove Today - Breaking & Trending Today

eli lilly share price: Lilly rides wave of weight-loss drug demand, working to expand capacity - Vimarsana News

eli lilly share price: Lilly rides wave of weight-loss drug demand, working to expand capacity

Shares were off about 1% at $696.82 after gaining about 11% in January, making Lilly the eighth largest company in the U.S. by market capitalization and most valuable healthcare company.

US FDA finds control lapses at Catalent plant being sold to Novo - Vimarsana News

US FDA finds control lapses at Catalent plant being sold to Novo

(Reuters) -U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a "pest" on the manufacturing line, according to an inspection report. Novo Holdings, the parent company of Novo Nordisk, on Monday announced it was buying Catalent in a $16.5 billion deal that included its Bloomington plant, which it plans to sell to Novo Nordisk to help it produce its popular weight-loss drug Wegovy. Catalent is already the main supplier of fill-finish work, or filling and packaging syringes an...

Source: yahoo.com
US FDA finds control lapses at Catalent plant being sold to Novo - Vimarsana News

US FDA finds control lapses at Catalent plant being sold to Novo

(Reuters) -U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a "pest" on the manufacturing line, according to an inspection report. Novo Holdings, the parent company of Novo Nordisk, on Monday announced it was buying Catalent in a $16.5 billion deal that included its Bloomington plant, which it plans to sell to Novo Nordisk to help it produce its popular weight-loss drug Wegovy. Catalent is already the main supplier of fill-finish work, or filling and packaging syringes an...

Source: yahoo.com
As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy - Vimarsana News

As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk will target launches of its popular obesity shot Wegovy in markets ...

As Lilly Rivalry Flares, Novo CEO Sets Out Wegovy Launch Strategy - Vimarsana News

As Lilly Rivalry Flares, Novo CEO Sets Out Wegovy Launch Strategy

Novo Nordisk will target launches of its popular obesity shot Wegovy in markets where it already has strong sales of its older weight-loss drug Saxenda, CEO Lars Fruergaard...